How full is our antihypertensives pipeline?
Dilip Gude1★★ Corresponding author
- 1Department of Internal Medicine, AMC, 3rd Floor, Medwin Hospital, Chirag Ali lane, Nampally, Hyderabad, Andhra Pradesh, India.
CORRESPONDENCE
Dilip Gude
Department of Internal Medicine, AMC, 3rd Floor, Medwin Hospital, Chirag Ali lane, Nampally, Hyderabad, Andhra Pradesh, India.
Volume 3, Issue 1 · pp. 7–8 · PUBLISHED 2012 · DOI: 10.4103/0976-500X.92492
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
We have a plethora of new antihypertensives coming up with diverse mechanisms of action but if that would drastically change and better the management of hypertension remains to be seen. A review of the newer classes of antihypertensives in the pipeline is presented.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Gude, D. (2012). How full is our antihypertensives pipeline?. Journal of Pharmacology and Pharmacotherapeutics, 3(1), 7–8. https://doi.org/10.4103/0976-500X.92492